■ HIGH RISK ■ Science & Research
The bench work is automating fast — robots extract, amplify, and sequence, and probabilistic software untangles the mixtures analysts once agonized over. The witness stand is the refuge: courts still require a qualified human to defend every result under cross-examination.
“Automated sequencing and AI interpretation. Your pipetting skills are legacy.”
Our AI replacement risk score — how we score jobs
A forensic DNA analyst turns evidence swabs into courtroom testimony: extracting DNA, quantifying it, amplifying STR loci, running capillary electrophoresis or increasingly sequencing, then the interpretive core — deciding which peaks are real alleles versus artifacts, untangling mixtures of two or more contributors, calculating match statistics, writing the report, and defending every step under defense cross-examination. Casework backlogs, contamination paranoia, and accreditation audits shape the days.
Automation owns the front half already. Liquid-handling robots perform extraction and PCR setup in high-throughput labs with better contamination control than human pipetting; rapid-DNA instruments compress swab-to-profile into under two hours with no analyst touch for reference samples. The interpretive middle is falling too: probabilistic genotyping software resolves mixed profiles that were once judgment calls or simply reported as inconclusive, and its statistical outputs have survived years of courtroom challenges. Expert systems auto-review clean single-source profiles — databasing samples flow through with minimal human review in modernized labs. Each layer converts analyst-hours into machine-hours, which is how backlogged public labs justify the capital.
What resists sits at the ends: evidence triage — deciding what to swab on a bloody, chaotic exhibit — and testimony. Courts require a qualified human to explain methods, defend the software's assumptions, and survive cross; accreditation standards require human technical review; and novel matters like forensic genetic genealogy demand investigative judgment machines don't have. Our 72 reflects a profession whose pipetting and routine interpretation are automating away while its accountability core — the person the jury watches — remains legally mandatory, in smaller numbers per case processed.
Automatability: our editorial assessment of current and near-term AI capability
Robotic sample processing and probabilistic genotyping are standard in well-funded labs now; expert-system review of routine profiles spreads through the late 2020s, letting labs clear backlogs without proportional hiring. By 2030 expect fewer analysts processing far more samples, with roles concentrated in complex casework, review, and testimony. Public-sector budget inertia slows the transition without reversing it.
Safer than the bench work suggests, riskier than the CSI glamour implies. Robots and software are absorbing extraction, routine interpretation, and databasing review, so labs will need fewer analysts per thousand samples. But accreditation and the courts require qualified humans for review and testimony, and complex casework keeps growing. Enter aiming at the judgment tier, not the pipette.
For clean single-source profiles, expert systems already review with minimal human involvement. For mixtures, probabilistic genotyping software does the mathematical heavy lifting, but a human analyst sets parameters, evaluates the output, and owns the conclusion. Courts admit the software's statistics precisely because a qualified analyst stands behind and explains them.
Statistical fluency with probabilistic genotyping, validation and quality-assurance expertise, courtroom communication, and emerging methods like forensic genetic genealogy and next-generation sequencing. The declining skills are manual processing and routine profile-reading. The analyst of 2030 is part statistician, part expert witness, part investigator.
They replace the routine slice — reference-sample processing for databasing and booking stations — which is real but bounded. Crime-scene evidence remains messy: degraded samples, mixtures, touch DNA on odd surfaces. That casework still routes to accredited labs and human analysts, and no rapid instrument testifies about what its result means.